Labcorp HoldingsLH +0.81%79 FCF Margin % is 1.99% as of Mar. 2026, which is 79% below its 10-year median of 9.33. GuruFocus rates LH with a GF Score™ of 79/100 and a GF Value™ of $271.41 (Fairly Valued). The stock has 6 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, Labcorp Holdings ranks better than 75.49% on this metric.
The historical rank and industry rank for Labcorp Holdings's FCF Margin % or its related term are showing as below:
LH'
s FCF Margin % Range Over the Past 10 Years
Min: 7.19 Med: 9.33 Max: 20.46
Current: 9.78
During the past 13 years, the highest FCF Margin % of Labcorp Holdings was 20.46%. The lowest was 7.19%. And the median was 9.33%.
LH's FCF Margin % is ranked better than 75.49% of 204
companies
in the Medical Diagnostics & Research industry
Industry Median: -1.845
vs LH: 9.78
Labcorp Holdings FCF Margin % Related Terms
Labcorp Holdings FCF Margin % Historical Data
* Premium members only.
The historical data trend for Labcorp Holdings's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Labcorp Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Labcorp Holdings FCF Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Labcorp Holdings's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Labcorp Holdings's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Labcorp Holdings (LH) has a FCF Margin % of 1.99% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Labcorp Holdings and its competitors. This is 79% below median its historical median of 9.33. Over the past decade, Labcorp Holdings' FCF Margin % has ranged from 7.19 to 20.46. According to the industry distribution chart, Labcorp Holdings ranks #50 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 24.5%.
Is Labcorp Holdings' FCF Margin % too high?
Labcorp Holdings' current FCF Margin % of 1.99% is 79% below median its 10-year median of 9.33. Over the past 10 years, this metric has ranged from a low of 7.19 to a high of 20.46. Based on the distribution chart, Labcorp Holdings ranks #50 out of 204 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Labcorp Holdings has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Labcorp Holdings' FCF Margin % compare to DGX and MTD?
According to the Medical Diagnostics & Research industry distribution chart, Labcorp Holdings ranks #50 out of 204 companies for FCF Margin %. This places Labcorp Holdings in the top 25% of its industry — outperforming the majority of peers. Historically, Labcorp Holdings' own FCF Margin % has ranged from 7.19 to 20.46 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Diagnostics & Research company?
A good FCF Margin % depends on the Medical Diagnostics & Research industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Labcorp Holdings and its competitors. Labcorp Holdings's current FCF Margin % is 1.99%, which is 79% below median its own 10-year median of 9.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labcorp Holdings stock overvalued right now?
Based on GuruFocus' analysis, Labcorp Holdings (LH) is currently considered Fairly Valued. The stock's GF Value™ is $271.41, compared to a current price of $267.34 — trading 1.5% below its estimated fair value. The current FCF Margin % is 1.99%, which is 79% below median its 10-year median of 9.33. Labcorp Holdings' overall GF Score™ is 79/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Labcorp Holdings (LH), the current FCF Margin % is 1.99% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Labcorp Holdings (LH) Overvalued in 2026?
Based on GuruFocus' analysis, Labcorp Holdings stock appears to be undervalued.
The current stock price of $267.34 is trading 1.5% below its estimated GF Value™ of $271.41.
GuruFocus considers Labcorp Holdings to be Fairly Valued.
Key valuation signals for LH:
FCF Margin %: 1.99% (79% below median its 10-year median of 9.33)
GF Value™: $271.41 vs. price of $267.34 (1.5% below fair value)
No single metric tells the full story. See the LH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.
79GF Score
Get the complete analysis for LH
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LH has been successfully added to your 
